Drug
Xiapex
Xiapex is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_4
2
33%
Ph phase_3
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Other(1)
Detailed Status
Completed5
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)
Trials by Status
completed583%
unknown117%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_4
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
NCT02647619
completed
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
NCT03331926
completed
Post Approval Commitment Study
NCT01444729
completednot_applicable
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
NCT01538017
unknownphase_4
Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture
NCT02476461
Clinical Trials (6)
Showing 6 of 6 trials
NCT02647619Phase 4
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
NCT03331926
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
NCT01444729
Post Approval Commitment Study
NCT01538017Not Applicable
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
NCT02476461Phase 4
Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture
NCT01229436Phase 3
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6